arrow
S

Surena F. Matin

The University of Texas MD Anderson Cancer Center
H指数:74
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MACHINE LEARNING-BASED PREDICTION OF PROGRESSION TO RADICAL NEPHROURETERECTOMY AFTER ENDOSCOPIC MANAGEMENT OF UPPER TRACT UROTHELIAL CARCINOMA

基于机器学习的上尿路尿路上皮癌内镜管理后进展至根治性肾输尿管切除术的预测

2026-05-010
PRE
LONG-TERM FOLLOW-UP RESULTS OF AMVAC ARM OF ECOG-ACRIN EA8141: A PROSPECTIVE PHASE II TRIAL OF NEOADJUVANT SYSTEMIC CHEMOTHERAPY FOLLOWED BY EXTIRPATIVE SURGERY FOR PATIENTS WITH HIGH-GRADE UPPER TRACT UROTHELIAL CARCINOMA

ECOG-ACRIN EA8141试验中AMVC组的长期随访结果:一项针对高危上尿路尿路上皮癌患者的新辅助全身化疗后行根治性手术的二期前瞻性临床试验

2026-05-010
PRE
Smoking is Associated With Poorer Survival Outcomes Following Nephroureterectomy for Upper Tract Urothelial Cancer

吸烟与上尿路尿路上皮癌根治性肾输尿管切除术后的较差生存结局相关

2026-01-010
PRE
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

高级泌尿肿瘤共识会议(AUC3)2025:肾细胞癌和尿路肿瘤管理的专家共识

2025-12-130
OAAI
Outcomes of endoscopic management for upper tract urothelial carcinoma: A multi-center international cohort analysis

上尿路尿路上皮癌的内镜管理结局:一项多中心国际队列分析

2025-11-010
PRE
A structured training curriculum for robot-assisted radical nephroureterectomy: a Delphi consensus study

机器人辅助根治性肾输尿管切除术的结构化培训课程:一项德尔菲共识研究

2025-09-170
PRE
Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes (vol 9, pg 1052, 2023)

UGN-101的给药途径及其对肿瘤学和安全性结果的影响 (第9卷,1052页,2023页)

2024-01-010
OAAI
Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract
2023-12-013
PRE
Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes

UGN-101的给药途径及其对肿瘤学和安全性结果的影响

2023-11-018
PRE